Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin + etoposide versus cisplatin + etoposide for first-line treatment of extensive-stage small cell lung cancer
ChiCTR-TRC-12002532Phase 4Completed
- Sponsor
- Beijing Chest Hospital
- Start
- Feb 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nedaplatin, cisplatin and etoposide in small cell lung cancer (SCLC) (2 arms), sponsored by Beijing Chest Hospital. Started Feb 2011; status: completed.
02
Drugs
nedaplatincisplatinetoposide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002532.